Finance

Lists
TSPC:IDX
Tempo Scan Pacific Tbk PT
IDR 2,330.00
-1.69%
(-40.00) 1D
Oct 21, 2:02:37 PM GMT+7  ·   IDR
All symbols
SymbolPriceChange% Change
Generating top insights for TSPC...
Open
IDR 2,380
High
IDR 2,400
Low
IDR 2,330
Mkt. cap
10.51T
Avg. vol.
563.60K
Volume
357.20K
Dividend
6.44%
Quarterly dividend
IDR 38
Ex-dividend date
Jun 17, 2026
P/E ratio
7.10
52-wk high
IDR 3,220
52-wk low
IDR 2,240
EPS
IDR 328
Shares outstanding
4.51B
No. of employees
4K
Open
IDR 2,380
High
IDR 2,400
Low
IDR 2,330
Mkt. cap
10.51T
Avg. vol.
563.60K
Volume
357.20K
Dividend
6.44%
Quarterly dividend
IDR 38
Ex-dividend date
Jun 17, 2026
P/E ratio
7.10
52-wk high
IDR 3,220
52-wk low
IDR 2,240
EPS
IDR 328
Shares outstanding
4.51B
No. of employees
4K
News stories
From web sources and news partners
About Tempo Scan Pacific Tbk PT
CEO-
Employees4.39K
Founded1970
Headquarters-
SectorPharmaceutical industry
Websitetemposcangroup.com
Previous reportsAll values in IDR
Loading Previous Earnings...
Revenue
Net income
All values in IDR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
3.54T
3.87T
3.41T
3.70T
Cost of goods sold
2.18T
2.36T
2.14T
2.34T
Cost of revenue
2.18T
2.36T
2.14T
2.34T
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
828.47B
1.19T
924.33B
965.06B
Operating expense
795.09B
1.18T
887.10B
860.67B
Total operating expenses
2.98T
3.54T
3.03T
3.20T
Operating income
558.58B
331.85B
385.84B
499.78B
Other non operating income
-13.68B
-1.25B
-3.42B
-140.99M
EBT including unusual items
588.09B
356.58B
409.30B
531.98B
EBT excluding unusual items
588.34B
358.04B
412.69B
532.78B
Income tax expense
141.03B
77.12B
59.31B
95.86B
Effective tax rate
23.98%
21.63%
14.49%
18.02%
Other operating expenses
-33.38B
-19.09B
-37.23B
-104.39B
Net income
434.11B
270.45B
351.81B
422.96B
Net profit margin
12.28%
6.99%
10.31%
11.44%
Earnings per share
-
-
-
-
Interest and investment income
58.34B
47.94B
44.60B
48.95B
Interest expense
-17.33B
-15.57B
-14.38B
-15.73B
Net interest expenses
41.01B
32.37B
30.23B
33.23B
Depreciation and amortization charges
-
-
-
-
EBITDA
636.86B
398.14B
453.11B
584.73B
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps